Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria

Transplant International

Volumn 27, Issue 6, 2014, Pages 562-569

  Jiang, Li ^a   Liao, Anque ^a   Wen, Tianfu ^a   Yan, Lunan ^a   Li, Bo ^a   Yang, Jiayin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

hepatocellular carcinoma; living donor liver transplantation; Milan criteria; multiple nodules; resection

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER TRANSPLANTATION; CHILD PUGH SCORE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER NODULE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MILAN CRITERIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; GRAFT REJECTION; GRAFT SURVIVAL; KAPLAN MEIER METHOD; LIVER NEOPLASMS; LYMPH NODE; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; SURGERY; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE;

ADULT; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901189431     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12297     Document Type: Article

References (25)

1. Mazzaferro V, Regalia E, Doci R, et al,. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
2. Figueras J, Jaurrieta E, Valls C, et al,. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 1997; 25: 1485.
3. Quintini C, Hashimoto K, Uso TD, Miller C,. Is there an advantage of living over deceased donation in liver transplantation? Transpl Int 2013; 26: 11.
4. Arii S, Yamaoka Y, Futagawa S, et al,. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32: 1224.
5. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373.
6. Koniaris LG, Levi DM, Pedroso FE, et al,. Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma? Ann Surg 2011; 254: 527.
7. Sapisochin G, Castells L, Dopazo C, et al,. Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol 2013; 20: 1194.
8. Imamura H, Matsuyama Y, Tanaka E, et al,. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200.
9. Shah SA, Cleary SP, Wei AC, et al,. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 2007; 141: 330.
10. Shah SA, Greig PD, Gallinger S, et al,. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006; 202: 275.
11. Choi D, Lim HK, Rhim H, et al,. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 2007; 17: 684.
12. Waki K, Aikata H, Katamura Y, et al,. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 2010; 25: 597.
13. Margarit C, Escartin A, Castells L, Vargas V, Allende E, Bilbao I,. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11: 1242.
14. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival. Ann Surg 2007; 245: 51.
15. Shah SA, Cleary SP, Tan JC, et al,. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol 2007; 14: 2608.
16. Facciuto ME, Rochon C, Pandey M, et al,. Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) 2009; 11: 398.
17. Bigourdan JM, Jaeck D, Meyer N, et al,. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9: 513.
18. Silva MF, Sapisochin G, Strasser SI, et al,. Liver resection and transplantation offer similar 5-year survival for Child-Pugh-Turcotte A HCC-patients with a single nodule up to 5 cm: a multicenter, exploratory analysis. Eur J Surg Oncol 2013; 39: 386.
19. Welker MW, Bechstein WO, Zeuzem S, Trojan J,. Recurrent hepatocellular carcinoma after liver transplantation-an emerging clinical challenge. Transpl Int 2013; 26: 109.
20. Bruix J, Sherman M,. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208.
21. Jonas S, Bechstein WO, Steinmüller T, et al,. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001; 33: 1080.
22. Lim HY, Sohn I, Deng S, et al,. Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression Profiling. Ann Surg Oncol 2013; 20: 3747.
23. Sasaki Y, Yamada T, Tanaka H, et al,. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg 2006; 244: 771.
24. Jiang L, Yan L, Li B, et al,. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant 2010; 10: 1861.
25. Jiang L, Yan L, Wen T, et al,. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation. Transplant Proc 2013; 45: 2326.